Please assess the completion status of the following clinical trial:

Trial Title: Intravitreal Celecoxib for Chronic Uveitis

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Chronic inflammation and/or macular edema despite maximal medical treatment Unable to tolerate corticosteroids due to side effects Aphakic or Pseudophakic subjects~Exclusion Criteria:~* 15 years or younger Have active ocular infection Pregnancy Phakic subjects

- Gender: ALL
- Minimum Age: 15 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Celecoxib (Type: EXPERIMENTAL): 1-4 mg intravitreal injection ofCelecoxib

Based on this trial design, predict the completion outcome and termination type (if applicable).